About Solaris Vaccines
Solaris Vaccines is a private company based in Fort Collins, Colorado, incorporated in 2021 in Delaware. It has reported $610,000 raised in two offerings on Form D since January 2022. Its chief executive is Michael Artinger.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 12, 2023 | May 19, 2023 | $110,000of $200K target | 3 | $36,667 | DebtRule 506(b) | Form D ↗ |
| Dec 27, 2021 | Jan 7, 2022 | $500,000fully sold | 1 | $500K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $610,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Solaris Vaccines's Form D filed May 19, 2023.
MA
Michael Artinger
CEO and director
RG
Robert Goforth
Director